Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RePHILL trial of pre-hospital blood products versus normal saline for traumatic haemorrhagic hypotension
ISRCTN62326938Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Oct 2016
- Modality
- Cell Therapies, Recombinant Proteins and Enzymes, Tissue Cells → Other Cell Types → Cell Therapies
01
Overview
Phase 3, randomised, open-label trial of red blood cells, LyoPlas and sodium chloride in Bleeding (2 arms), sponsored by University Hospitals Birmingham. Primary endpoints: Episode mortality to 30 days and Lactate clearance. Started Oct 2016; status: completed.
02
Drugs
red blood cellsLyoPlassodium chloride
03
Conditions
Bleeding
Beyond the preview
Go deeper on ISRCTN62326938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62326938.